Constitutive activation of the transcription factor NF-κB results in impaired Borna disease virus replication

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 6043-6051

  Bourteele, Soizic ^a   Oesterle, Katja ^a   Pleschka, Stephan ^b   Unterstab, Gunhild ^c   Ehrhardt, Christina ^d   Wolff, Thorsten ^c   Ludwig, Stephan ^d,e   Planz, Oliver ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; CELL NUCLEUS; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEMALE; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GUINEA PIG; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; REPORTER GENE; RNA VIRUS; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION INITIATION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BORNA DISEASE; BORNA DISEASE VIRUS; BRAIN; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GUINEA PIGS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RATS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

BORNA DISEASE VIRUS; CAVIA PORCELLUS; RNA VIRUSES; SUS SCROFA;

EID: 18144430213     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.6043-6051.2005     Document Type: Article

References (60)

1. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 413:732-738.
2. Amsterdam, J. D., A. Winokur, W. Dyson, S. Herzog, F. Gonzalez, R. Rott, and H. Koprowski. 1985. Borna disease virus. A possible etiologic factor in human affective disorders? Arch. Gen. Psychiatry 42:1093-1096.
3. Au, W. C., P. A. Moore, W. Lowther, Y. T. Juang, and P. M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92:11657-11661.
4. Barton, G. H. M., and R. Medzhitov. 2003. Linking Toll-like receptors to IFN-alpha/beta expression. Nat. Immunol. 4:432-433.
5. Berg, M., C. Ehrenborg, J. Blomberg, R. Pipkorn, and A. L. Berg. 1998. Two domains of the Borna disease virus p40 protein are required for interaction with the p23 protein. J. Gen. Virol. 79:2957-2963.
6. Bilzer, T., and L. Stitz. 1994. Immune-mediated brain atrophy. CD8+ T cells contribute to tissue destruction during Borna disease. J. Immunol. 153:818-823.
7. Bode, L., W. Zimmermann, R. Ferszt, F. Steinbach, and H. Ludwig. 1995. Borna disease virus genome transcribed and expressed in psychiatric patients. Nat. Med. 1:232-236.
8. Briese, T., W. I. Lipkin, and J. C. de la Torre. 1995. Molecular biology of Borna disease virus. Curr. Top. Microbiol. Immunol. 190:1-16.
9. Carbone, K. M., S. A. Rubin, Y. Nishino, and M. V. Pletnikov. 2001. Borna disease: virus-induced neurobehavioral disease pathogenesis. Curr. Opin. Microbiol. 4:467-475.
10. Chariot, A., A. Leonardi, J. Muller, M. Bonif, K. Brown, and U. Siebenlist. 2002. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J. Biol. Chem. 277:37029-37036.
11. Chu, W. M., D. Ostertag, Z. W. Li, L. F. Chang, Y. Chen, Y. L. Hu, B. Williams, J. Perrault, and M. Karin. 1999. JNK2 and IKK beta are required for activating the innate response to viral infection. Immunity 11:721-731.
12. Denk, A., M. Goebeler, S. Schmid, I. Berberich, O. Ritz, D. Lindemann, S. Ludwig, and T. Wirth. 2001. Activation of NF-kappa B via the I kappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J. Biol. Chem. 276:28451-28458.
13. Deschl, U., L. Stitz, S. Herzog, K. Frese, and R. Rott. 1990. Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease. Acta Neuropathol. 81:41-50.
14. Diaz, M. O., S. Ziemin, M. M. Lebeau, P. Pitha, S. D. Smith, R. R. Chilcote, and J. D. Rowley. 1988. Homozygous deletion of the alpha-interferon and beta-1-interferon genes in human-leukemia and derived cell-lines. Proc. Natl. Acad. Sci. USA 85:5259-5263.
15. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496.
16. Foy, E., K. Li, C. Wang, R. Sumpter, Jr., M. Ikeda, S. M. Lemon, and M. Gale, Jr. 2003. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145-1148.
17. Fridmacher, V., B. Kaltschmidt, B. Goudeau, D. Ndiaye, F. M. Rossi, J. Pfeiffer, C. Kaltschmidt, A. Israel, and S. Memet. 2003. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J. Neurosci. 23:9403-9408.
18. Furrer, E., T. Bilzer, L. Stitz, and O. Planz. 2001. High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology. J. Virol. 75:11700-11708.
19. Furrer, E., T. Bilzer, L. Stitz, and O. Planz. 2001. Neutralizing antibodies in persistent Borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis. J. Virol. 75:943-951.
20. Hallensleben, W., and P. Staeheli. 1999. Inhibition of Borna disease virus multiplication by interferon: cell line differences in susceptibility. Arch. Virol. 144:1209-1216.
21. Hans, A., S. Syan, C. Crosio, P. Sassone-Corsi, M. Brahic, and D. Gonzalez-Dunia. 2001. Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells. J. Biol. Chem. 276:7258-7265.
22. Hashimoto, Y., H. S. Chen, C. Cunningham, T. H. Malik, and P. K. Lai. 2003. Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization. J. Virol. 77:6076-6081.
23. Hiscott, J., H. Kwon, and P. Genin. 2001. Hostile takeovers: viral appropriation of the NF-kappa B pathway. J. Clin. Investig. 107:143-151.
24. Israel, A. 2000. The IKK complex: an integrator of all signals that activate NF-kappa B? Trends Cell Biol. 10:129-133.
25. Jehle, C., I. Herpfer, M. Rauer, M. Schwemmle, and C. Sauder. 2003. Identification of differentially expressed genes in brains of newborn Borna disease virus-infected rats in the absence of inflammation. Arch. Virol. 148:45-63.
26. Jordan, I., and W. I. Lipkin. 2001. Borna disease virus. Rev. Med. Virol. 11:37-57.
27. Kaltschmidt, B., T. Sparna, and C. Kaltschmidt. 1999. Activation of NF-kappa B by reactive oxygen intermediates in the nervous system. Antioxid. Redox Signal. 1:129-144.
28. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P. A. Baeuerle. 1994. Constitutive NF-κB activity in neurons. Mol. Cell. Biol. 14:3981-3992.
29. Kishi, M., Y. Arimura, K. Ikuta, Y. Shoya, P. K. Lai, and M. Kakinuma. 1996. Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells. J. Virol. 70:635-640.
30. Lin, R. T., C. Heylbroeck, P. M. Pitba, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
31. Ludwig, H., and L. Bode. 2000. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology. Rev. Sci. Tech. 19:259-288.
32. Ludwig, S., O. Planz, S. Pleschka, and T. Wolff. 2003. Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol. Med. 9:46-52.
33. Majde, J. A. 2000. Viral double-stranded RNA, cytokines, and the flu. J. Interferon Cytokine Res. 20:259-272.
34. Morimoto, K., D. C. Hooper, A. Bornborst, S. Corisdeo, M. Bette, Z. F. Fu, M. K. Scbafer, H. Koprowski, E. Weihe, and B. Dietzschold. 1996. Intrinsic responses to Borna disease virus infection of the central nervous system. Proc. Natl. Acad. Sci. USA 93:13345-13350.
35. Nakamura, Y., H. Takahashi, Y. Shoya, T. Nakaya, M. Watanabe, K. Tomonaga, K. Iwahashi, K. Ameno, N. Momiyama, H. Taniyama, T. Sata, T. Kurata, J. C. de la Torre, and K. Ikuta. 2000. Isolation of Borna disease virus from human brain tissue. J. Virol. 74:4601-4611.
36. + T cells. J. Biol. Chem. 276:13689-13694.
37. Planz, O., S. Pleschka, and S. Ludwig. 2001. Mek-specific inhibitor u0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75:4871-4877.
38. Planz, O., S. Pleschka, K. Oesterle, F. Berberich-Siebelt, C. Ehrhardt, L. Stitz, and S. Ludwig. 2003. Borna disease virus nucleoprotein interacts with the Cdc2-cyclin B1 complex. J. Virol. 77:11186-11192.
39. Planz, O., C. Rentzsch, A. Batra, H.-J. Rziha, and L. Stitz. 1998. Persistence of Borna disease virus-specific nucleic acid in the blood of a psychiatric patient. Lancet 352:623.
40. Planz, O., H. J. Rziha, and L. Stitz. 2003. Genetic relationship of Borna disease virus isolates. Virus Genes 26:25-30.
41. +-T-cell-mediated immune response. J. Virol. 73:1715-1718.
42. Plata-Salaman, C. R., S. E. Ilyin, D. Gayle, A. Romanovitch, and K. M. Carbone. 1999. Persistent Borna disease virus infection of neonatal rats causes brain regional changes of mRNAs for cytokines, cytokine receptor components and neuropeptides. Brain Res. Bull. 49:441-451.
43. Richt, J. A., L. Stitz, H. Wekerle, and R. Rott. 1989. Borna disease, a progressive meningoencephalomyelitis as a model for CD4+ T cell-mediated immunopathology in the brain. J. Exp. Med. 170:1045-1050.
44. Sato, M., N. Tanaka, N. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425:112-116.
45. Sauder, C., W. Hallensleben, A. Pagenstecher, S. Schneckenburger, L. Biro, D. Pertlik, J. Hausmann, M. Suter, and P. Staeheli. 2000. Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation. J. Virol. 74:9267-9280.
46. Schamel, K., P. Staeheli, and J. Hausmann. 2001. Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein. J. Virol. 75:8579-8588.
47. Schwemmle, M., M. Salvatore, L. Shi, J. Richt, C. H. Lee, and W. I. Lipkin. 1998. Interactions of the Borna disease virus P, N, and X proteins and their functional implications. J. Biol. Chem. 273:9007-9012.
48. Shankar, V., M. Kao, A. N. Hamir, H. Sheng, H. Koprowski, and B. Dietzschold. 1992. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J. Virol. 66:992-998.
49. Sharma, S., B. R. Tenover, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
50. Staeheli, P., M. Sentandreu, A. Pagenstecher, and J. Hausmann. 2001. Alpha/beta interferon promotes transcription and inhibits replication of Borna disease virus in persistently infected cells. J. Virol. 75:8216-8223.
51. Stitz, L., T. Bilzer, and O. Planz. 2002. The immunopathogenesis of Borna disease virus infection. Front. Biosci. 7:d541-d555.
52. Stitz, L., K. Noske, O. Planz, E. Furrer, W. I. Lipkin, and T. Bilzer. 1998. A functional role for neutralizing antibodies in Borna disease: influence on virus tropism outside the central nervous system. J. Virol. 72:8884-8892.
53. Tamatani, M., Y. H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno, and M. Tohyama. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538.
54. Tanigucbi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
55. Thiedemann, N., P. Presek, R. Rott, and L. Stitz. 1992. Antigenic relationship and further characterization of two major Borna disease virus-specific proteins. J. Gen. Virol. 73:1057-1064.
56. von Rheinbaben, F., L. Stitz, and R. Rott. 1985. Influence of interferon on persistent infection caused by Borna disease virus in vitro. J. Gen. Virol. 66:2777-2780.
57. Wang, X., M. Li, H. Zheng, T. Muster, P. Palese, A. A. Beg, and A. Garcia-Sastre. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
58. Wathelet, M. G., C. H. Lin, B. S. Parekh, L. V. Ronco, P. M. Howley, and T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1:507-518.
59. Wolff, T., R. Pfleger, T. Wehner, J. Reinhardt, and J. A. Richt. 2000. A short leucine-rich sequence in the Borna disease virus p10 protein mediates association with the viral phospho- and nucleoproteins. J. Gen. Virol. 81:939-947.
60. Yabe, T., D. Wilson, and J. P. Schwartz. 2001. NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J. Biol. Chem. 276:43313-43319.